April 23rd 2024
The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Cases and Conversations™: Evidence-Based Approaches to Management of CKD in Your Patients with T2DM
September 25, 2024
Register Now!
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
3rd Annual International Congress on Pediatric Oncology
October 25, 2024
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
FDA approves teplizumab for delay of type 1 diabetes in patients 8 years and up
November 18th 2022The US FDA announced the approval of teplizumab (Tzield), which is administered through IV infusion once daily for 14 consecutive days, for delaying the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.
Study finds children, young adults with down syndrome more likely to develop diabetes
October 17th 2022An analysis of data from more than 9900 people with Down syndrome and 38,000 controls provides new insight into the apparent increase in risk of developing diabetes among children and young adults with Down syndrome.
In gestational diabetes, tighter glycemic targets could influence outcomes for mother and child
September 23rd 2022Results of the TARGET trial provide insight into the effects of tight glycemic targets versus less tight targets on maternal and perinatal outcomes among women with gestational diabetes.
In pediatric type 1 diabetes, race, income, insurance remain barriers to insulin pump use
June 22nd 2022An analysis of the SEARCH for Youth in Diabetes details historic and contemporary disparities in insulin pump use for pediatric type 1 diabetes based on racial/ethnic background, household income, and insurance type.
Exposure to marijuana in utero tied to early life increased fat mass, glucose levels
April 4th 2022An analysis of more than 100 mother-child pairs from Colorado found children with fetal exposure to cannabis had increased fat mass and fasting glucose levels compared to their counterparts without fetal exposure to cannabis.
When puberty arrives too early or too late
October 9th 2021Puberty will happen for every child, but when it arrives early or is delayed both parent and child may be worried. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition discussed typical reasons for both early and delayed pubertal development.
Extended-wear insulin infusion set leads to greater satisfaction in type 1 diabetes
June 28th 2021A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.
How early childhood nutrition influences future cardiometabolic risks
June 27th 2021The impact of nutrition in the first years of life on future cardiometabolic health has been generally understood, although gaps about certain populations remain. A session at the virtual Scientific Sessions for the American Diabetes Association sought to fill the gap for Native American children.
Using provider education to expand specialty diabetes care to the underserved
June 26th 2021For many underserved type 1 diabetes patients the ability to seek specialist care is out of reach for a variety of reasons. One program discussed at the virtual Scientific Sessions for the American Diabetes Association seeks to change that by empowering primary care providers through education to provide much-needed specialist care to those patients.
Should adult criteria for prediabetes be applied to youngsters?
February 6th 2020A study of hemoglobin A1c (HbA1c) levels that compared levels in normal-weight and obese middle schoolers found that overall distribution of HbA1c was similar in the 2 groups and that the adult-defined cutoff was seen in 2% of normal-weight youth.
Thyroid disorders: Manifestations, evaluation, and management in children and adolescents
August 15th 2019Thyroid disorders present with overt symptoms or insidiously with few signs of disease. Here’s how pediatricians can identify and effectively treat children with thyroid disease or refer patients for further evaluation.